Abstract:Abstract Colorectal cancer, recognized as a quintessential age-related disease, underscores the intricate interplay between aging mechanisms and disease pathogenesis. Cellular senescence, a DNA damage-induced cellular stress response, is characterized by cell cycle arrest, the expression of an inflammatory senescence-associated secretory phenotype, and alterations in extracellular matrix metabolism. It is widely recognized as a fundamental and evolutionarily conserved mechanism of aging. Guided by geroscience principles, which assert that the pathogenesis of age-related diseases involves cellular mechanisms of aging, this study delves into the role of senescence-related genes in colon cancer progression. Leveraging a gene set reflective of senescence-associated pathways, we employed uni- and multivariate Cox proportional hazards survival analysis combined with the determination of the false discovery rate to analyze correlations between gene expression and survival. The integrated database of 1130 colon cancer specimens with available relapse-free survival time and relapse event data from ten independent cohorts provided a robust platform for survival analyses. We identified senescence-related genes associated with differential expression levels linked to shorter survival. Our findings unveil a prognostic signature utilizing cellular senescence-related genes (hazard ratio: 2.73, 95% CI 2.12–3.52, p = 6.4E − 16), offering valuable insights into survival prediction in colon cancer. Multivariate analysis underscored the independence of the senescence-related signature from available epidemiological and pathological variables. This study highlights the potential of senescence-related genes as prognostic biomarkers. Overall, our results underscore the pivotal role of cellular senescence, a fundamental mechanism of aging, in colon cancer progression.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to explore the prognostic significance of genes related to cellular senescence in colorectal cancer. Specifically, researchers hope to predict the survival of colorectal cancer patients by analyzing the gene expression patterns related to cellular senescence, and identify genes that can serve as prognostic biomarkers. ### Research Background Colorectal cancer is a disease highly associated with age, and its incidence increases significantly with age. Cellular senescence is a cellular stress response caused by DNA damage, manifested as cell - cycle arrest, expression of the senescence - associated secretory phenotype (SASP), and changes in extracellular matrix metabolism. These changes are not only involved in the aging process but also related to the pathogenesis of various age - related diseases, including cancer. ### Research Objectives The main objective of this study is to evaluate the prognostic value of these genes in colorectal cancer patients by analyzing the gene expression patterns related to cellular senescence. Researchers hope to discover a prognostic signature based on genes related to cellular senescence to help predict patient survival and provide new insights into the clinical management of colorectal cancer. ### Methods 1. **Data Collection**: Researchers collected gene expression data and survival time data of 1,130 colorectal cancer patients from multiple public databases. 2. **Data Processing**: The original gene expression data was normalized, and the JetSet algorithm was used to select the most reliable probe sets. 3. **Survival Analysis**: Cox proportional - hazards models were used for univariate and multivariate survival analysis to evaluate the relationship between gene expression and patient survival. 4. **Multivariate Analysis**: Combined with clinical and pathological parameters (such as gender, T - stage, N - stage, M - stage, tumor grade, microsatellite instability, etc.), the independent prognostic value of the cellular senescence - related gene signature was further verified. ### Results 1. **Univariate Survival Analysis**: The signature based on genes related to cellular senescence was significantly associated with the recurrence - free survival rate of colorectal cancer patients (HR = 2.73, 95% CI = 2.12 - 3.52, p = 6.4e - 16). 2. **Multivariate Analysis**: The cellular senescence - related gene signature still had significant prognostic value in multivariate analysis and was independent of other clinical and pathological parameters. 3. **Validation in Different Datasets**: In multiple independent datasets, this signature also showed consistent prognostic ability. ### Discussion The research results indicate that genes related to cellular senescence play an important role in the prognosis of colorectal cancer. These genes can not only predict the survival of patients but also may reveal the molecular mechanisms of colorectal cancer progression. Future research can further verify these findings and explore treatment strategies targeting cellular senescence - related pathways to improve the prognosis of colorectal cancer patients. ### Conclusion This study successfully identified a gene signature with significant prognostic value by analyzing the expression patterns of genes related to cellular senescence in colorectal cancer. This finding provides new ideas and potential biomarkers for the clinical management and treatment of colorectal cancer.

Prognostic significance of a signature based on senescence-related genes in colorectal cancer

Senescence-related genes as prognostic indicators in breast cancer survival

Senescence-related signatures predict prognosis and response to immunotherapy in colon cancer

Comprehensive genomics analysis of aging related gene signature to predict the prognosis and drug resistance of colon adenocarcinoma

The aging-related risk signature in colorectal cancer

Identification and Validation of a Novel DNA Damage and DNA Repair Related Genes Based Signature for Colon Cancer Prognosis

Development of an Aging-Related Gene Signature for Predicting Prognosis, Immunotherapy, and Chemotherapy Benefits in Rectal Cancer

Development and Validation of a Novel Epigenetic Signature for Predicting Prognosis in Colon Cancer.

A senescence-based prognostic gene signature for colorectal cancer and identification of the role of SPP1-positive macrophages in tumor senescence

Cell Senescence-Related Genes as Biomarkers for Prognosis and Immunotherapeutic Response in Colon Cancer

Effect of Aging-Related Genes on the Prognosis of Colon Cancer

Exploring the role of cellular senescence in cancer prognosis across multiple tumor types

Investigating the role of senescence biomarkers in colorectal cancer heterogeneity by bulk and single-cell RNA sequencing

Prognosis signature for predicting the survival and immunotherapy response in esophageal carcinoma based on cellular senescence-related genes

Construction and validation of an aging-related gene signature predicting the prognosis of pancreatic cancer

A Seven-Gene Signature Predicts Overall Survival of Patients with Colorectal Cancer

Identification of a novel senescence-associated signature to predict biochemical recurrence and immune microenvironment for prostate cancer

A Prognostic Signature Associated with Cell Senescence Predicts Survival Outcomes and Strongly Associates with Immunotherapy and Chemotherapy Response in Breast Cancer

Prognostic aging gene-based score for colorectal cancer: unveiling links to drug resistance, mutation burden, and personalized treatment strategies

P1192 Deciphering the colonic immune landscape of UC from cellular senescence by integrated bioinformatics analysis and machine learning

Deciphering the predictive value of senescence-related signature in lung adenocarcinoma: Implications for antitumor immunity and immunotherapy efficacy